Skip to content

Clinical trials

Phase 3 Glomerulosclerosis, Focal Segmental trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Glomerulosclerosis, Focal Segmental Phase: Phase 3 Clear all

8 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20032
20041
20182
20221
20241
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed4
Recruiting2
Active, not recruiting1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)2
Boehringer Ingelheim1
Dimerix Bioscience Pty Ltd1
Hospital Authority, Hong Kong1
Radboud University Medical Center1
The Hospital for Sick Children1
Travere Therapeutics, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Glomerulosclerosis, Focal Segmental8
Nephrosis, Lipoid3
Kidney Diseases2
Glomerulonephritis, Membranous1
Nephrosis1
Nephrotic Syndrome1
Osteoporosis1
Proteinuria1

Trials

Showing 1 to 8 of 8. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.